FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Teva's long-acting methylphenidate hydrochloride product. This action confirms regulatory authorization to market th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate hydrochloride (LA) (Methylphenidate hydrochloride)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE)